ArticleCellular oncology (Dordrecht, Netherlands)2020

Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.

Majid Momeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.